PharmChem, Inc.
PCHM
$3.40
$0.0270.80%
OTC PK
09/30/2003 | 06/30/2003 | 03/31/2003 | 12/31/2002 | 09/30/2002 | |
---|---|---|---|---|---|
Net Income | -136.05% | -208.69% | 50.23% | 139.43% | 136.00% |
Total Depreciation and Amortization | -4.70% | 7.09% | 9.92% | 11.00% | 6.89% |
Total Amortization of Deferred Charges | -24.12% | 34.11% | 101.16% | 302.33% | 5,566.67% |
Total Other Non-Cash Items | 85.20% | 103.21% | 100.80% | -699.59% | -654.68% |
Change in Net Operating Assets | -200.00% | 119.79% | -120.11% | -103.38% | -111.84% |
Cash from Operations | -213.61% | 225.48% | 105.70% | 137.07% | 162.31% |
Capital Expenditure | 70.01% | 75.07% | 77.73% | 73.18% | 62.92% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -100.00% | -100.00% | -100.00% | -- | -- |
Other Investing Activities | 193.11% | 100.00% | 100.00% | 42.86% | -635.62% |
Cash from Investing | -101.28% | -112.93% | -121.70% | 259.87% | 237.76% |
Total Debt Issued | 48,122.22% | -- | -- | -- | -99.89% |
Total Debt Repaid | -62.86% | 38.58% | -23.97% | -74.97% | -81.25% |
Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 100.00% | 100.00% | -100.00% | -177.41% | -143.19% |
Cash from Financing | 57.43% | -148.04% | -190.24% | -163.32% | -158.56% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -262.61% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -169.45% | -153.02% | -159.96% | 2,194.86% | 326.47% |